PETRACCI, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 1.504
NA - Nord America 808
EU - Europa 559
SA - Sud America 128
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 64
OC - Oceania 1
Totale 3.134
Nazione #
US - Stati Uniti d'America 775
CN - Cina 469
SG - Singapore 385
VN - Vietnam 290
IT - Italia 232
KR - Corea 106
BR - Brasile 94
HK - Hong Kong 69
BD - Bangladesh 63
DE - Germania 60
GB - Regno Unito 54
NL - Olanda 45
FR - Francia 43
IN - India 37
SE - Svezia 35
CI - Costa d'Avorio 32
FI - Finlandia 26
JP - Giappone 25
CA - Canada 17
RU - Federazione Russa 17
AR - Argentina 16
IE - Irlanda 13
SC - Seychelles 11
ID - Indonesia 9
PH - Filippine 9
MX - Messico 7
TH - Thailandia 7
ZA - Sudafrica 7
JO - Giordania 6
TG - Togo 6
CL - Cile 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
UA - Ucraina 4
BE - Belgio 3
BG - Bulgaria 3
EC - Ecuador 3
EE - Estonia 3
ES - Italia 3
GR - Grecia 3
IR - Iran 3
PY - Paraguay 3
SA - Arabia Saudita 3
TR - Turchia 3
TW - Taiwan 3
UY - Uruguay 3
AT - Austria 2
CR - Costa Rica 2
GT - Guatemala 2
HR - Croazia 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
PL - Polonia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LS - Lesotho 1
MA - Marocco 1
ME - Montenegro 1
OM - Oman 1
PK - Pakistan 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.065
Città #
Singapore 289
Hefei 230
Ashburn 137
San Jose 106
Seoul 101
Ho Chi Minh City 82
Hong Kong 67
Hanoi 65
Council Bluffs 42
Fairfield 39
Bologna 38
Southend 33
Abidjan 32
Chandler 29
Beijing 27
Los Angeles 25
Santa Clara 25
New York 22
Tokyo 22
Woodbridge 21
Bengaluru 20
Boardman 20
Milan 20
Seattle 20
Lauterbourg 19
Wilmington 19
São Paulo 18
Cambridge 17
Lappeenranta 17
Rome 15
Dublin 13
Houston 13
Frankfurt am Main 12
Munich 11
Da Nang 10
Turin 10
Forlì 9
Buffalo 8
Haiphong 8
Helsinki 8
Princeton 8
Hillsboro 7
Montreal 7
Naples 7
Tongling 7
Amman 6
Falkenstein 6
Jakarta 6
Lomé 6
Redondo Beach 6
Bo 5
Bắc Ninh 5
Dallas 5
Düsseldorf 5
Falls Church 5
Florence 5
Thái Bình 5
Amsterdam 4
Ann Arbor 4
Chengdu 4
Genoa 4
Nanjing 4
Nuremberg 4
Belo Horizonte 3
Berlin 3
Biên Hòa 3
Brooklyn 3
Can Tho 3
Chicago 3
Elk Grove Village 3
Freiburg im Breisgau 3
Guangzhou 3
Johannesburg 3
Montevideo 3
Ninh Bình 3
Pilsen 3
Quận Bình Thạnh 3
Rancho Palos Verdes 3
Russi 3
Shenyang 3
Sofia 3
Stockholm 3
Tianjin 3
Vũng Tàu 3
Westminster 3
Apodaca 2
Baghdad 2
Bangkok 2
Bekasi 2
Bremen 2
Changsha 2
Charlotte 2
Chongqing 2
Dalian 2
Dhaka 2
Dongguan 2
Eagleville 2
Gessate 2
Guayaquil 2
Hebei 2
Totale 1.940
Nome #
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 261
Coronally advanced flap with and without connective tissue graft for the treatment of multiple gingival recessions: a comparative short- and long-term controlled randomized clinical trial 248
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 218
ELECTROMYOGRAPHIC ANALYSIS OF LEG EXTENSION EXERCISE DURING DIFFERENT ANKLE AND KNEE POSITIONS 212
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 193
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 184
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 175
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 171
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 165
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience 160
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival 156
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 151
INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia 147
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 140
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients 126
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 108
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients 106
Venetoclax plus hypomethylating agents as effective bridge therapy to allogeneic stem cell transplant in relapsed/refractory acute myeloid leukaemia: A subanalysis of the AVALON study 97
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA 57
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients 55
Risk factor modification and projections of absolute breast cancer risk 2
Variance computations for functionals of absolute risk estimates 2
Totale 3.134
Categoria #
all - tutte 7.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202292 0 6 2 4 10 6 3 4 6 6 21 24
2022/2023137 8 17 7 12 8 7 3 7 26 2 25 15
2023/2024105 1 6 11 6 8 11 11 14 10 22 2 3
2024/2025592 30 47 28 45 36 15 22 15 5 91 87 171
2025/20261.896 264 272 162 172 119 59 132 85 318 113 85 115
2026/202788 42 46 0 0 0 0 0 0 0 0 0 0
Totale 3.134